Leitlinie „Behandlung der Akne“ - AWMF
Leitlinie „Behandlung der Akne“ - AWMF
Leitlinie „Behandlung der Akne“ - AWMF
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
013/017 - Behandlung <strong>der</strong> Akne aktueller Stand: 02/2010<br />
korrigierte Fassung: 10/2011<br />
256. Cunliffe WJ. Evolution of a strategy for the treatment of acne. J Am Acad Dermatol.<br />
1987; 16: 591-9.<br />
257. Greenwood R, Brummitt L, Burke B, Cunliffe WJ. Acne: double blind clinical and<br />
laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined<br />
treatment. Br Med J (Clin Res Ed). 1985; 291: 1231-5.<br />
258. Zouboulis CC, Orfanos C. Retinoids. In: Millikan LE: Drug Therapy in Dermatology.<br />
New York, Basel: Marcel Dekker, 2000: 171-233. ISBN: 0824703065<br />
259. Ganceviciene R, Zouboulis CC. Isotretinoin: state of the art treatment for acne<br />
vulgaris. Exp Rev Dermatol. 2007; 2: 693-706.<br />
260. Papakonstantinou E, Aletras AJ, Glass E, Tsogas P, Dionyssopoulos A, Adjaye J,<br />
Fimmel S, Gouvousis P, Herwig R, Lehrach H, Zouboulis CC, Karakiulakis G. Matrix<br />
metalloproteinases of epithelial origin in facial sebum of patients with acne and their<br />
regulation by isotretinoin. J Invest Dermatol. 2005; 125: 673-84.<br />
261. Zouboulis CC. Isotretinoin revisited: pluripotent effects on human sebaceous gland<br />
cells. J Invest Dermatol. 2006; 126: 2154-6.<br />
262. Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne.<br />
Dermatology. 1998; 196: 140-7.<br />
263. Strauss JS, Rapini RP, Shalita AR, Konecky E, Pochi PE, Comite H, Exner JH.<br />
Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad<br />
Dermatol. 1984; 10: 490-6.<br />
264. Pigatto PD, Finzi AF, Altomare GF, Polenghi MM, Vergani C, Vigotti G. Isotretinoin<br />
versus minocycline in cystic acne: a study of lipid metabolism. Dermatologica. 1986;<br />
172: 154-9.<br />
265. Prendiville JS, Logan RA, Russell-Jones R. A comparison of dapsone with 13-cis<br />
retinoic acid in the treatment of nodular cystic acne. Clin Exp Dermatol. 1988; 13: 67-<br />
71.<br />
266. Zouboulis CC, Piquero-Martin J. Update and future of systemic acne treatment.<br />
Dermatology. 2003; 206: 37-53.<br />
267. Lehucher-Ceyrac D, de La Salmoniere P, Chastang C, Morel P. Predictive factors for<br />
failure of isotretinoin treatment in acne patients: results from a cohort of 237 patients.<br />
Dermatology. 1999; 198: 278-83.<br />
268. Quereux G, Volteau C, N'Guyen JM, Dreno B. Prospective study of risk factors of<br />
relapse after treatment of acne with oral isotretinoin. Dermatology. 2006; 212: 168-76.<br />
269. Meigel W, Gollnick H, Wokalek H, Plewig G. [Oral treatment of acne conglobata<br />
using 13-cis-retinoic acid. Results of the German multicentric study following 24<br />
weeks of treatment]. Hautarzt. 1983; 34: 387-97.<br />
270. Plewig G, Hennes R, Maas B, Mack-Hennes A. [Remission behavior following lowdose<br />
13-cis-retinoic acid in papulopustular acne]. Z Hautkr. 1986; 61: 1205-10.<br />
271. Zouboulis CC. The truth behind this undeniable efficacy--recurrence rates and relapse<br />
risk factors of acne treatment with oral isotretinoin. Dermatology. 2006; 212: 99-100.<br />
272. Layton AM, Dreno B, Gollnick HP, Zouboulis CC. A review of the European<br />
directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol<br />
Venereol. 2006; 20: 773-6.<br />
273. Hai<strong>der</strong> A, Shaw JC. Treatment of acne vulgaris. Jama. 2004; 292: 726-35.<br />
Seite 122 von 136
Change language